Treatment Resistant Psychosis

1. What is the decision or change you are facing or struggling with where a summary of the evidence would be helpful?

We are interested in down regulation of dopamine for better treatment outcomes for schizophrenic patients. We are interested in this because antipsychotics reduce the chemical dopamine, but also upregulate dopamine which gives schizophrenia patients psychosis (visual and auditory hallucinations) that becomes treatment resistant.

2. Why are you struggling with this issue?

There is currently no solution.

3. What do you want to see changed? How will you know that your issue is improving or has been addressed?

When there are any few companies that do the research, create the medication, do the trials, get passed by the FDA, get administered to the public, and it works for all who have treatment resistant psychosis, then I will know that the issue has improved.

4. When do you need the evidence report?

Tue, 06/30/2020

5. What will you do with the evidence report?

The evidence report will be saved.

(Optional) About You

What is your role or perspective? Patient

If you are you making a suggestion on behalf of an organization, please state the name of the organization: N/A

May we contact you if we have questions about your nomination? Yes